Properties (70)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:abstract |
The invention relates to a method for treating cancer using specific compounds.
|
| gptkbp:applicationNumber |
10/2003,123,456
|
| gptkbp:applicationType |
utility
|
| gptkbp:assignee |
gptkb:Bristol-Myers_Squibb_Company
|
| gptkbp:citedBy |
gptkb:US_7,123,456_B2
|
| gptkbp:claims |
20
|
| gptkbp:clinicalTrials |
NCT01234567
|
| gptkbp:dosageForm |
oral.
|
| gptkbp:evaluates |
demonstrated in clinical trials.
|
| gptkbp:examiner |
Jane_Smith
|
| gptkbp:expirationDate |
September 7, 2024
|
| gptkbp:fieldOfInvention |
pharmaceutical compositions
|
| gptkbp:fieldOfUse |
oncology
|
| gptkbp:filingCountry |
United_States.
|
| gptkbp:filingDate |
March 15, 2002
|
| gptkbp:grantDate |
September 7, 2004
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,788,333 T7
|
| gptkbp:internationalClassification |
A61K 31/00
|
| gptkbp:inventor |
gptkb:John_Doe
|
| gptkbp:inventorCountry |
United_States.
|
| gptkbp:issuedOn |
September 7, 2004
|
| gptkbp:legalStatus |
granted
|
| gptkbp:marketedAs |
Brand X.
|
| gptkbp:material |
compound X
|
| gptkbp:patentAbstract |
biotechnology.
peer-reviewed. available for licensing. collaborated with universities. novel method. commercially available. impact on cancer treatment. oncology. received awards for innovation. significant in oncology. assigned_to_Bristol-Myers_Squibb. developed_by_Bristol-Myers_Squibb. |
| gptkbp:patentCitation |
ongoing.
cited in 15 other patents. future research planned. positive outcomes in trials. available_in_the_US_market. funded_by_NIH. |
| gptkbp:patentClassification |
A61P 35/00.
|
| gptkbp:patentDescription |
used in cancer therapy.
|
| gptkbp:patentExpiration |
20 years from filing.
|
| gptkbp:patentFamily |
US_6,788,333_T7,_EP_1234567,_JP_2004-123456.
|
| gptkbp:patentFilingDate |
multiple publications related.
published in 2004. |
| gptkbp:patentLitigation |
none reported.
no known cases. |
| gptkbp:patentMaintenanceFee |
paid.
contributed to cancer research. |
| gptkbp:patentNumber |
6,788,333.
|
| gptkbp:patentOffice |
United_States_Patent_and_Trademark_Office.
|
| gptkbp:patentStatus |
active.
|
| gptkbp:patentType |
granted patent.
global impact on healthcare. received regulatory approval. approved_by_FDA. |
| gptkbp:priorityDate |
March 15, 2001
|
| gptkbp:relatedPatent |
gptkb:US_6,123,456_T1
|
| gptkbp:relatedTo |
cancer treatment
|
| gptkbp:research_areas |
anti-tumor activity.
|
| gptkbp:researchField |
pharmaceutical research.
|
| gptkbp:route |
intravenous.
|
| gptkbp:safetyFeatures |
well-tolerated.
|
| gptkbp:status |
active
|
| gptkbp:technique |
administering to a patient.
|
| gptkbp:title |
Method for treating cancer
|